Parkinson's Disease Natural History Study
Part of Brain & nervous system clinical trials.
This study follows people with Parkinson's disease over time to understand how the disease progresses and changes. Researchers will collect information about your symptoms, brain health, and overall wellness to help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed Parkinson's disease diagnosis by at least two neurologists using standard criteria
- Able to complete standard Parkinson's symptom assessments (UPDRS rating scale)
- Able to complete a brief memory and thinking test (Mini-Mental State Exam)
- No history of stroke, head injury, or encephalitis (brain inflammation)
- No other serious conditions like cancer, severe organ problems, blood disorders, or autoimmune diseases
- Not diagnosed with Parkinson-plus syndromes (atypical forms like MSA or PSP)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This research examines how the gut and brain are connected in Parkinson's disease and aims to better understand the disease. You'd participate in visits and tests over three years, including some involving your digestive system.
This study is a registry that collects information from people with Parkinson’s disease to better understand the condition. You may help researchers learn about patterns of symptoms and care over time.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
This study looks at people newly diagnosed with Parkinson’s disease, before starting Parkinson’s medicines, to better understand early illness. It may help researchers identify patterns that could guide future treatments.
Hear when a new Parkinson Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.